Syneos Health (FRA:8IN) 3-Year Revenue Growth Rate : 7.10% (As of Jun. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Syneos Health 3-Year Revenue Growth Rate?

Syneos Health's Revenue per Share for the three months ended in Jun. 2023 was €12.08.

During the past 12 months, Syneos Health's average Revenue per Share Growth Rate was 6.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was 7.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was 8.40% per year. During the past 10 years, the average Revenue per Share Growth Rate was 14.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 12 years, the highest 3-Year average Revenue per Share Growth Rate of Syneos Health was 25.30% per year. The lowest was 4.50% per year. And the median was 18.90% per year.

Competitive Comparison of Syneos Health's 3-Year Revenue Growth Rate

For the Diagnostics & Research subindustry, Syneos Health's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Syneos Health's 3-Year Revenue Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Syneos Health's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Syneos Health's 3-Year Revenue Growth Rate falls into.

Syneos Health 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Syneos Health (FRA:8IN) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Syneos Health 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Syneos Health's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Syneos Health (FRA:8IN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Syneos Health Inc (FRA:8IN) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

1030 Sync Street, Morrisville, NC, USA, 27560-5468

Website

https://www.syneoshealth.com

Syneos is a global contract research and outsourced commercialization organization that provides services to pharmaceutical and biotechnology firms. Its clinical solutions segment offers early- to late-stage clinical trial support that ranges from specialized staffing models to strategic partnerships that oversee nearly all aspects of a drug program, while the company's commercialization solutions includes outsourced sales, consulting, public relations, and advertising services.

Syneos Health (FRA:8IN) Headlines

No Headlines